Trials / Completed
CompletedNCT03415750
Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants
A Single-center,Randomized,Open-label,12 Months Study,2 Parallel Group to Compare the Efficacy of Everolimus Combination + Tacrolimus in Regression of Left Ventricular Hypertrophy vs Tacrolimus + MMF in Renal Transplant Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Edoardo Melilli · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical study with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the maintenance phase.
Detailed description
A single-center, randomized, open-label, 12 months study, with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the maintenance phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Everolimus | Conversion from Mycophenolate mofetil to Everolimus |
| DRUG | Mycophenolate mofetil | Patients will remain in Tacrolimus + Mycophenolate mofetil |
| DRUG | Tacrolimus |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2018-01-30
- Last updated
- 2021-01-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03415750. Inclusion in this directory is not an endorsement.